Youming Zhang
Directeur/Membre du Conseil chez FUFENG GROUP LIMITED
Postes actifs de Youming Zhang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FUFENG GROUP LIMITED | Directeur/Membre du Conseil | 01/04/2021 | - |
| Independent Dir/Board Member | 01/04/2021 | - | |
| Shandong University | Corporate Officer/Principal | - | - |
Historique de carrière de Youming Zhang
Anciens postes connus de Youming Zhang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Gene Bridges GmbH
 Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Directeur Technique/Scientifique/R&D | - | 01/01/2013 |
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - | - |
Formation de Youming Zhang
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Xiamen University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistiques
Internationale
| Chine | 5 |
| Allemagne | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FUFENG GROUP LIMITED | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Gene Bridges GmbH
Gene Bridges GmbH BiotechnologyHealth Technology Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
- Bourse
- Insiders
- Youming Zhang
- Expérience